PharmaShots | Incisive News in 3 Shots

Subscribe Now

Enspryng

Genentech to Present New Data of Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder at MSVirtual2020

Genentech to Present New Data of Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder at MSVirtual2020

September 10, 2020

Roche's Enspryng (satralizumab-mwge) Receives the US FDA's Approval for Neuromyelitis Optica Spectrum Disorder

Roche's Enspryng (satralizumab-mwge) Receives the US FDA's Approval for Neuromyelitis Optica Spectrum Disorder

August 17, 2020

Roche's Enspryng (satralizumab) Receives MHLW's Approval for Neuromyelitis Optica Spectrum Disorder in Japan

Roche's Enspryng (satralizumab) Receives MHLW's Approval for Neuromyelitis Optica Spectrum Disorder in Japan

June 29, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us